Gedeon Richter Investment In Formycon Opens Up Collaboration Opportunities
Firm Takes 9% Stake In German Biosimilars Developer, Which Receives Over €80m
• By David Wallace
Gedeon Richter’s investment will help fund Formycon’s biosimilar development • Source: Shutterstock 
